Fenfluramine

CHEMBL87493 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
231.3 g/mol
LogP
3.4
Phase
4

This medication was re-approved at very low doses specifically to reduce seizure frequency in rare childhood epilepsies such as Dravet syndrome and Lennox-Gastaut syndrome. It works through serotonin signaling pathways and specific receptors in the brain.

Peso Molecular

231,2600 g/mol

LogP

3,40

TPSA

12,00 Ų

Regra dos 5 de Lipinski

Aprovado

Áreas Terapêuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCNC(C)Cc1cccc(C(F)(F)F)c1

InChI

InChI=1S/C12H16F3N/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15/h4-6,8-9,16H,3,7H2,1-2H3

Molecular Formula

C12H16F3N

HBD / HBA

1 / 4

Ligações Rotacionáveis

4

Átomos Pesados

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

This medication was re-approved at very low doses specifically to reduce seizure frequency in rare childhood epilepsies such as Dravet syndrome and Lennox-Gastaut syndrome. It works through serotonin signaling pathways and specific receptors in the brain.

Yes, Fenfluramine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL87493. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3337. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.